2017-01-26 - Full MAG Meeting (Conf call)
Date : 26 January 2016 20:00 UTC
GoToMeeting Details
Objectives
Review and agree actions on all currently active work items.
Discussion items
Description | Owner | Time mins | Notes | Work Plan Item / RoadMap | Action (Deliver for April Conference) | |
|---|---|---|---|---|---|---|
| 1 | Start GTM Recording Meeting Introduction Robert's Departure GA Expectations | PWI | 5 | 5 hours per month? MAG is one of larger AGs. Need to demonstrate value. |
| N/A |
| 2 | SNOMED CT OWL2 EL Logic Profile
| YGA | 10 | Anatomy, Drug projects. Benefits: Anatomy case study? What can we express with new constructs? Representation of OWL in RF2, but also implication of additional constructs on existing view. Internal work - Demonstration of Anatomy classification with additional constructs. DMA: Decouple Logic Profile Questions from distribution of OWL - makes it easier to add to profile. However no point in distributing OWL if not adding value over RF2. GCI problem inherent in making Part Ofs defining. Distribute logical definition, not "extras" in OWL eg descriptions should be left in existing RF2. Suggested secondary concept file with OWL definition in definition status field, to remove overhead of maintaining refset. These would be stated relationships for concepts. Limitations are in relationship file, not RF2. Update: SubGroup Membership: Add Michael Lawley. See Work Item page for current sub-group membership. | Needed for 2018+ delivery of Anatomy Priority/Start/End
2017/8 Roadmap delivery date should set priority. | @All Summary of Benefits - for lay audience. @Yongsheng Gao Proposal for roadmap. Options & recommendation for representing logic profile (aim for end June) @Peter Williams Review of Concrete Domain Proposal @Yongsheng Gao set up regular two weekly call. |
| 3 | Drug and Device update
| TMO | 10 | Devices: Currently attempting to organise hierarchies by device characteristics.
Drugs: see slides  |
| N/A |
| 4 | HS | 10 | Are conclusions correct? Harold said a couple of additional ones had come up. Harold attempted to run against US edition and encountered a number of issues. Finalize document for April |
| @Former user (Deleted) @Peter Williams Set up pages to contain US issues and discussion on options for representing descriptions. | |
| 5 | Role Group 0 | DK / YGA | 10 | See Implicitness of relationship grouping Presentation at Wellington meeting October 2016 -- Tooling impact re single attributes in groups. Check in Jim Case. |
| @Daniel Karlsson (Unlicensed) @Yongsheng Gao Guidance on use of Role Group 0 and impact on formation of OWL for classification. Also impact for other projects - LOINC, Observables. @Peter Williams Email discussion page to group / feedback on presentation. Some experimentation needed. |
| 6 | RC | 5 | Current status and plan. Work progressing re attributes of existing processes eg automated/edited, language/model, etc.
|
| @Ronald Cornet (Unlicensed)
| |
| 7 | What is the MAG Purpose, process & scope & timing? | YGA / PWI | 5 | When do MAG get involved to best help large projects eg substance, drug model. cf Editorial AG |
| @Peter Williams - Add page explaining MAG intention and contribution. |
| 8 | LBI | 5 | Update: Feedback on the draft is now closed. The plan is to publish the MRCM as a beta alongside the January 31st 2017 international edition. Feedback will be welcome on the beta, once published. | Complete until MRCM released. Beta issued with the Jan 31 release. | N/A | |
| 9 | Any Other Business | PWI | 5 | Agenda items for April Conference.
|
|
Attendees
Apologies
Previous Meetings
| Title | Creator | Modified |
|---|---|---|
| No content found. | ||
Meeting Files
Copyright © 2025, SNOMED International